Lou Arcudi
- Role
- Chief Financial Officer at Amolyt Pharma
- Location
- Boston, MA, US
- LinkedIn followers
- 500 followers
About Lou Arcudi
Accomplished, visionary Chief Executive Officer / Chief Financial Officer with…
Experience
Chief Financial Officer
Jul 2021 — Present
About Amolyt Pharma Amolyt Pharma is building on its team’s established expertise in therapeutic peptides to deliver life-changing treatments to patients suffering from rare endocrine and metabolic diseases. Its portfolio includes AZP-3601 as a potential treatment of hypoparathyroidism, AZP-38XX, a small peptide series under evaluation to select a development candidate for the treatment of acromegaly, and AZP-3404, which is undergoing indication selection work. Amolyt Pharma aims to further expand and develop its portfolio by leveraging its global network in the field of endocrinology and with support from a strong syndicate of international investors. To learn more, visit or follow us on Twitter at @AmolytPharma.
Education
Southern New Hampshire University
BS, Business
1978 — 1982
Bryant University
MBA, Finance
1984 — 1987
Babson College
Certificate, International Studies
1983 — 1983
Skills
- Business Strategy
- Mergers
- Finance
- Negotiation
- Private Equity
- Strategic Planning
- Investor Relations
- Divestitures
- Cross-Functional Team Leadership
- Leadership
- Start-Ups
- Forecasting
- Technology Transfer
- Biotechnology
- Venture Capital
- Acquisition Integration
- Analysis
- Financial Modeling
- Executive Management
- Sec Filings
- Mergers & Acquisitions
- Valuation
- Due Diligence
- Revenue Recognition
- Financial Reporting
- Financial Analysis
- Sarbanes-Oxley Act
- Corporate Development
- Corporate Finance
- Fundraising
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.